PLOS ONE | https://doi.org/10.1371/journal.pone.0192068 March 9, 2018
F1000Research 2019, 8:323 Last updated: 17 MAY 2019
Updated version June 2015
A feasibility study in five African sites
Ghana Med J. 2012 Jun;46(2 Suppl):69-78.
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Capability and Performance
These guidelines will assist the ICMR institutions/ centers/ Hqrs. by providing information on the policies, principles and approaches which should be followed in carrying out procurement of goods and services at their respective institute/ center/ Hqrs.
The Journal of Infection in Developing Countries 7(3):289-292
Panam Salud Publica. 2021;45:e22. https://doi.org/10.26633/RPSP.2021.22
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...ls in the Democratic Republic of the Congo between August 2005 and September 2009 to support the registration of pafuramidine for treatment of first stage HAT in collaboration with the United States Food and Drug Administration. Patients were treated with either 100 mg of pafuramidine orally twice a day for 10 days or 4 mg/kg pentamidine intramuscularly once daily for 7 days to assess the efficacy and safety of pafuramidine versus pentamidine. Pregnant and lactating women as well as adolescents were included.
more